C

Clover Biopharmaceuticals Ltd
HKEX:2197

Watchlist Manager
Clover Biopharmaceuticals Ltd
HKEX:2197
Watchlist
Price: 0.92 HKD 15% Market Closed
Market Cap: 1.2B HKD
Section:
Wall Street Price Targets
Wall Street Price Targets
Revenue Forecast
Operating Income Forecast
Net Income Forecast
See Also
Price Target
Loading...
Revenue
Loading...
Operating Income
Loading...
Net Income
Loading...

Wall Street
Price Targets

Price Targets Summary
Clover Biopharmaceuticals Ltd

There are no price targets for Clover Biopharmaceuticals Ltd.
Lowest Forecast
Wall Street Target
Not Available
Average Forecast
Wall Street Target
Not Available
Highest Forecast
Wall Street Target
Not Available
Lowest
Price Target
Not Available
Average
Price Target
Not Available
Highest
Price Target
Not Available
Clover Biopharmaceuticals Ltd Competitors:
Price Targets
F
FLUO
Fluoguide AS
162% Upside
SBTX
SkinBioTherapeutics PLC
104% Upside
MDGL
Madrigal Pharmaceuticals Inc
11% Upside
ALXO
ALX Oncology Holdings Inc
123% Upside
F
FLUO
Fluoguide AS
162% Upside
SBTX
SkinBioTherapeutics PLC
104% Upside
MDGL
Madrigal Pharmaceuticals Inc
11% Upside
ALXO
ALX Oncology Holdings Inc
123% Upside
E
206650
EuBiologics Co Ltd
43% Upside
M
GLUE
Monte Rosa Therapeutics Inc
269% Upside
300653
Yantai Zhenghai Bio-Tech Co Ltd
16% Upside
REGN
Regeneron Pharmaceuticals Inc
26% Upside

Revenue
Forecast

Revenue Estimate
Clover Biopharmaceuticals Ltd

The compound annual growth rate of Clover Biopharmaceuticals Ltd's revenue for the next 1 year is 6 116%.

N/A
Past Growth
6 116%
Estimated Growth
N/A
Estimates Accuracy
N/A
Average
What are analyst estimates?

Operating Income
Forecast

Operating Income Estimate
Clover Biopharmaceuticals Ltd

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
11%
Average Beat
What are analyst estimates?

Net Income
Forecast

Net Income Estimate
Clover Biopharmaceuticals Ltd

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
N/A
Average
What are analyst estimates?

See Also

Summary
Intrinsic value, competitors valuation, and company profile.
DCF Valuation
Stock valuation using Discount Cash Flow valuation method.
Relative Valuation
Stock valuation using valuation multiples.
Wall Street Estimates
Price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
Stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is Clover Biopharmaceuticals Ltd's stock price target?
Not Available

Clover Biopharmaceuticals Ltd doesn't have any price targets made by Wall Street professionals.

What is Clover Biopharmaceuticals Ltd's Revenue forecast?
Projected CAGR
6 116%

The compound annual growth rate of Clover Biopharmaceuticals Ltd's revenue for the next 1 year is 6 116%.

Back to Top
ALPHA SPREAD
Follow us
Join more than 277,000+ value investors using Alpha Spread
Create Free Account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks Wide Economic Moat Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2025 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.